(19)
(11) EP 0 974 671 A8

(12) CORRECTED EUROPEAN PATENT APPLICATION
published in accordance with Art. 158(3) EPC

(48) Corrigendum issued on:
03.07.2002 Bulletin 2002/27

(43) Date of publication:
26.01.2000 Bulletin 2000/04

(21) Application number: 98935306.5

(22) Date of filing: 31.07.1998
(51) International Patent Classification (IPC)7C12P 21/08, G01N 33/53, C07K 16/24
(86) International application number:
PCT/JP9803/421
(87) International publication number:
WO 9915/691 (01.04.1999 Gazette 1999/13)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB IE IT LI LU NL PT SE

(30) Priority: 24.09.1997 JP 27647597

(71) Applicant: Sankyo Company, Limited
Tokyo 103-8426 (JP)

(72) Inventors:
  • YANO, Kazuki
    Shimotsuga-gun, Tochigi 329-0511 (JP)
  • KOBAYASHI, Fumie
    Kawachi-gun, Tochigi 329-1104 (JP)
  • GOTO, Masaaki
    Shimotsuga-gun, Tochigi 329-0502 (JP)
  • WASHIDA, Naohiro
    Shimotsuga-gun, Tochigi 329-0518 (JP)
  • TSUDA, Eisuke
    Kawachi-gun, Tochigi 329-0434 (JP)
  • HIGASHIO, Kanji
    Kawagoe-shi, Saitama 350-0822 (JP)
  • YAMADA, Yoshiji
    Nagoya-shi, Aichi 458-0013 (JP)

(74) Representative: Wakerley, Helen Rachael 
Reddie & Grose, 16 Theobalds Road
London WC1X 8PL
London WC1X 8PL (GB)

   


(54) METHOD FOR DIAGNOSING BONE DYSBOLISM


(57) A method of diagnosing metabolic bone diseases, especially osteoporosis and arthrosis characterized by determining the concentration of osteoclastgenesis inhibitory factor (OCIF) in humor. Monoclonal antibodies recognizing equally both of monomer type and dimer type of OCIF. Monoclonal antibodies recognizing selectively dimer type of OCIF. And to provide an assay kit for determination of OCIF concentration comprising the aforementioned two antibodies recognizing different epitope of OCIF and having high affinity showing dissociation constant of less than 2 x 10-7 M with antigen. It is useful for a method of diagnosing metabolic bone diseases, especially osteoporosis and arthrosis or for an assay reagent for research thereof.